Latest It Consulting News

Sultan Resources reports steady progress in its Western Australia gold and Canadian lithium projects while pausing nickel drilling due to market conditions, supported by a recent capital raise.

Arrow Minerals reports a breakthrough at its Niagara Bauxite Project with high-grade mineralisation over 14km² and advances metallurgical testwork at Simandou North, backed by a $7 million funding round.

MetalsTech Limited has secured a $5 million working capital facility and engaged Mining One to complete a Pre-Feasibility Study for its Sturec Gold Mine in Slovakia, following an updated Scoping Study that reveals strong project economics.

Lykos Metals Limited reports significant high-grade mineral findings at its Sinjakovo Project and extends its Jezero exploration permit, alongside key board appointments and cost restructuring.

Felix Gold Limited is advancing plans for near-term antimony production at its historic Scrafford Mine in Alaska, backed by a recent $4.8 million capital raise and strategic positioning amid critical mineral shortages in the U.S.

Pilot Energy Limited has announced a substantial 58% increase in the carbon storage capacity of its Cliff Head project, alongside securing $6.3 million in capital and advancing a joint venture for Direct Air Capture technology.

Aspire Mining Limited has made significant strides in developing its Ovoot Coking Coal Project, progressing construction tenders and customer engagement despite a challenging coal market.

ReNu Energy reports progress on a management buyout proposal for its hydrogen subsidiary and completes sale of legacy geothermal assets, signaling a strategic pivot and ongoing capital challenges.

Excite Technology Services has achieved positive EBITDA in December 2024, driven by strong revenue growth and record customer receipts, notably from its Digital Forensics division and the integration of CDFS.

Vectus Biosystems reports completion of Phase Ib trials for its lead drug VB0004 and a robust cash position bolstered by a significant R&D tax refund, setting the stage for licensing discussions.

Arovella Therapeutics has bolstered its financial position with a $20 million placement, fully funding the Phase 1 clinical trial of its lead CAR-iNKT therapy, ALA-101, targeting CD19-positive blood cancers. The company also established a Clinical Advisory Board and anticipates key regulatory and clinical milestones in 2025.

Emperor Energy has secured $3 million through a share placement to fund the Judith-2 Well development, appointing a suite of technical consultants to accelerate progress in the Gippsland Basin. The company’s strategic moves position it to unlock significant gas resources critical for South-Eastern Australia’s energy supply.